Amicus Therapeutics logo
Amicus Therapeutics FOLD
$ 9.64 1.42%

Quarterly report 2024-Q3
added 11-06-2024

report update icon

Amicus Therapeutics Balance Sheet 2011-2024 | FOLD

Annual Balance Sheet Amicus Therapeutics

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Net Debt

149 M 252 M 152 M 233 M 317 M 666 M 425 M - 117 M -9.72 M -29.2 M -33.3 M -24.6 M

Long Term Debt

388 M 392 M 389 M 389 M 150 M 322 M 164 M - 41.6 M 10.5 M 14.2 M 299 K -

Long Term Debt Current

8.32 M 8.55 M 7.41 M 6.87 M 7.19 M - - - - - - - -

Total Non Current Liabilities

- - - - 245 M 361 M 204 M - 487 M 67.6 M 71.4 M 31.6 M 20.9 M

Total Current Liabilities

168 M 139 M 146 M 130 M 129 M 86.1 M 70 M 111 M 73.6 M 20.2 M 10.5 M 9.24 M 19.3 M

Total Liabilities

618 M 601 M 598 M 600 M 374 M 447 M 274 M - 561 M 87.8 M 81.8 M 40.9 M 40.2 M

Deferred Revenue

- - - - - - - - - - - - 8.5 M

Retained Earnings

-2.68 B -2.53 B -2.3 B -2.05 B -1.77 B -1.41 B -1.06 B - -580 M -447 M -379 M -319 M -270 M

Total Assets

778 M 724 M 905 M 887 M 850 M 790 M 627 M - 908 M 210 M 128 M 110 M 69.8 M

Cash and Cash Equivalents

247 M 149 M 245 M 163 M 143 M 79.7 M 49.1 M 187 M 69.5 M 24.1 M 43.6 M 34 M 25.7 M

Book Value

160 M 123 M 307 M 286 M 476 M 343 M 353 M - 348 M 122 M 45.8 M 69.2 M 29.6 M

Total Shareholders Equity

160 M 123 M 307 M 286 M 476 M 343 M 353 M 360 M 348 M 122 M 45.8 M 69.2 M 29.6 M

All numbers in USD currency

Quarterly Balance Sheet Amicus Therapeutics

2024-Q3 2024-Q2 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Long Term Debt

389 M 389 M 388 M 394 M 393 M 393 M 392 M 391 M - 390 M 389 M 389 M 390 M 390 M 389 M 389 M 389 M 389 M 150 M 150 M 53.5 M 53.5 M - - - - - - - - - 22 M 21.9 M 38.5 M 41.6 M - - - - - - - - - - - - - - - - - - -

Total Non Current Liabilities

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Total Liabilities

608 M 617 M 618 M 631 M 619 M 598 M 601 M 627 M - 588 M 598 M 580 M 573 M 559 M 600 M 600 M 600 M 600 M 374 M 374 M 374 M 374 M 447 M 447 M 447 M 447 M 274 M 274 M 274 M 274 M - - - - - - - - - - - - - - - - - - - - - - - -

Deferred Revenue

- - - - - - - - - - - - - - - - - - 4 M - - - 9 M - - - - - - - - - - - - - - - - - - - - - - - - - 7.93 M 8.19 M 8.5 M 9.27 M 8.5 M 8.5 M

Retained Earnings

-2.75 B -2.75 B -2.68 B -2.65 B -2.63 B -2.59 B -2.53 B -2.48 B - -2.38 B -2.3 B -2.21 B -2.16 B -2.11 B -2.05 B -2.05 B -2.05 B -2.05 B -1.77 B -1.77 B -1.77 B -1.77 B -1.41 B -1.41 B -1.41 B -1.41 B -1.06 B -1.06 B -1.06 B -1.06 B -780 M -780 M -780 M -780 M -580 M -580 M -580 M -580 M -447 M -447 M -447 M -447 M -379 M -379 M -379 M -379 M -319 M -319 M -319 M -319 M -270 M -270 M -270 M -270 M

Total Assets

787 M 749 M 778 M 764 M 730 M 701 M 724 M 760 M - 827 M 905 M 957 M 787 M 810 M 887 M 887 M 887 M 887 M 850 M 850 M 850 M 850 M 790 M 790 M 790 M 790 M 627 M 627 M 627 M 627 M 1.04 B 1.04 B 1.04 B 1.04 B 908 M 908 M 908 M 908 M 210 M 210 M 210 M 210 M 128 M 128 M 128 M 128 M 110 M 110 M 110 M 110 M 69.8 M 69.8 M 69.8 M 69.8 M

Cash and Cash Equivalents

234 M 209 M 247 M 263 M 211 M 161 M 149 M 278 M 236 M 233 M 245 M 386 M 177 M 185 M 163 M 163 M 163 M 163 M 143 M 143 M 143 M 143 M 79.7 M 79.7 M 79.7 M 79.7 M 49.1 M 49.1 M 49.1 M 49.1 M 187 M 187 M 187 M 187 M 69.5 M 69.5 M 69.5 M 69.5 M 24.1 M 24.1 M 24.1 M 24.1 M 43.6 M 43.6 M 43.6 M 43.6 M 34 M 34 M 34 M 34 M 25.7 M 25.7 M 25.7 M 25.7 M

Book Value

179 M 133 M 160 M 133 M 112 M 103 M 123 M 133 M - 239 M 307 M 377 M 214 M 251 M 286 M 286 M 286 M 286 M 476 M 476 M 476 M 476 M 343 M 343 M 343 M 343 M 353 M 353 M 353 M 353 M 1.04 B 1.04 B 1.04 B 1.04 B 908 M 908 M 908 M 908 M 210 M 210 M 210 M 210 M 128 M 128 M 128 M 128 M 110 M 110 M 110 M 110 M 69.8 M 69.8 M 69.8 M 69.8 M

Total Shareholders Equity

179 M 133 M 160 M 133 M 112 M 103 M 123 M 133 M 173 M 239 M 307 M 377 M 214 M 251 M 286 M 286 M 286 M 286 M 476 M 476 M 476 M 476 M 343 M 343 M 343 M 343 M 353 M 353 M 353 M 353 M 360 M 360 M 360 M 360 M 348 M 348 M 348 M 348 M 122 M 122 M 122 M 122 M 45.8 M 45.8 M 45.8 M 45.8 M 69.2 M 69.2 M 69.2 M 69.2 M 29.6 M 29.6 M 29.6 M 29.6 M

All numbers in USD currency